Glucagon‐like peptide‐1 (GLP‐1) signalling in the brain: From neural circuits and metabolism to therapeutics
Open Access
- 4 November 2021
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 179 (4) , 600-624
Abstract
Glucagon‐like‐peptide‐1 (GLP‐1) derived from gut enteroendocrine cells and a discrete population of neurons in the caudal medulla acts through humoral and neural pathways to regulate satiety, gastric motility and pancreatic endocrine function. These physiological attributes contribute to GLP‐1 having a potent therapeutic action in glycaemic regulation and chronic weight management. In this review, we provide an overview of the neural circuits targeted by endogenous versus exogenous GLP‐1 and related drugs. We also highlight candidate subpopulations of neurons and cellular mechanisms responsible for the acute and chronic effects of GLP‐1 and GLP‐1 receptor agonists on energy balance and glucose metabolism. Finally, we present potential future directions to translate these findings towards the development of effective therapies for treatment of metabolic disease.LINKED ARTICLES: This article is part of a themed issue on GLP1 receptor ligands (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.4/issuetocKeywords
Funding Information
- National Institutes of Health (R01 DK119169, DK119130‐5830)
This publication has 149 references indexed in Scilit:
- Deconstruction of a neural circuit for hungerNature, 2012
- Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretionDiabetologia, 2012
- Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in miceJournal of Clinical Investigation, 2011
- GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanismEuropean Journal of Pharmacology, 2011
- Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditureBrain Research, 2010
- Paraventricular hypothalamic nucleus: Axonal projections to the brainstemJournal of Comparative Neurology, 2009
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)The Lancet, 2009
- Oxytocin: The Great Facilitator of LifeProgress in Neurobiology, 2009
- Hypothalamic leptin regulation of energy homeostasis and glucose metabolismThe Journal of Physiology, 2007
- Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditureJournal of Clinical Investigation, 2007